Portland Psychiatric Services

Portland Psychiatric Services in Portland, Oregon offers Spravato for adults with treatment-resistant depression. The FDA-approved esketamine nasal spray targets a different pathway in the brain than traditional antidepressants and may provide rapid relief for patients who have not found success with other treatments.

Spravato is administered under medical supervision through the restricted Spravato REMS program, which ensures the medication is given only in a certified clinical setting. Unlike conventional antidepressants that can take weeks to work, esketamine is fast-acting.

The practice focuses on helping patients with depression that has not responded to standard care, offering esketamine as part of supervised psychiatric treatment. Portland Psychiatric Services provides care for adults seeking new options for difficult-to-treat depression.